Related Experiment Videos
The pathologist in the 21st century--generalist or specialist?
1Department of Histopathology, Royal Sussex County Hospital, Brighton, UK. nigelk@pavilion.co.uk
Journal of Clinical Pathology
|April 18, 2000
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Methotrexate toxicity during treatment of chronic plaque psoriasis: a case report and review of the literature.
Dermatology and therapy·2014
Loss of wild-type p53 and C-erbb2 amplification correlates with high-grade breast carcinomas.
International journal of oncology·2011
Mesenchymal chondrosarcoma of the orbit: an unusual site for a rare tumour.
European journal of cancer care·2009
U.K. guidelines for the management of cutaneous melanoma.
The British journal of dermatology·2002
UK guidelines for the management of cutaneous melanoma.
British journal of plastic surgery·2002
ALK overexpression without rearrangement widely exists in EWSR1/FUS-rearranged soft tissue tumours.
Journal of clinical pathology·2026
Adapt or Become Irrelevant: the Pathologist as the new Diagnostic Architect.
Journal of clinical pathology·2026
Targeted transcriptome profiling of oral cavity squamous cell carcinoma and histologic grade-associated gene expression patterns.
Journal of clinical pathology·2026
Serum versus lithium-heparin plasma for lipid testing: matrix-related bias and calculated LDL-C classification.
Journal of clinical pathology·2026
Beyond root cause analysis: a practical systems engineering approach to incident investigation in histopathology.
Journal of clinical pathology·2026
Plasmacytomas in Extramedullary Manifestation of Multiple Myeloma: A Case Report.
Clinical medicine insights. Case reports·2026
Plexiform Fibrohistiocytic Tumor: An Updated Review.
In vivo (Athens, Greece)·2026
ERG and CD31 expression in acute megakaryoblastic leukemia and myeloid sarcoma: A diagnostic pitfall.
Annals of diagnostic pathology·2026
Neoehrlichiosis Causing Hemolytic Anemia in Patients Treated with Rituximab, Norway, 2024-2025.
Emerging infectious diseases·2026